查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1536677

轻度认知障碍市场，按适应症、按疾病类型、按年龄组、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Mild Cognitive Impairment Market, By Indication, By Disease Type, By Age Group, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年，轻度认知障碍市场规模为 1,98,021 万美元，2024 年至 2032 年复合年增长率为 5.24%。

轻度认知障碍市场-市场动态

人口老化和诊断方法的进步预计将推动市场需求

随着人口的增加，MCI 和其他认知障碍的盛行率也会增加。越来越多的旧燃料需要诊断工具、处理方法和管理策略。医疗保健提供者和公众对 MCI 有了更高的认识和理解。诊断方法的进步和教育力度的加强有助于提高检出率和随后对介入措施的需求。

此外，认知健康及相关领域医疗保健支出的增加推动了 MCI 相关产品和服务的需求。政府和私营部门正在投资更好的认知障碍护理解决方案。认知训练应用程式、远距医疗和穿戴式装置等数位健康技术的兴起增强了 MCI 的管理和监控。科技提高了患者的参与度，并为治疗和研究提供了新的途径。旨在控制症状或改变 MCI 进展的药物的开发会影响市场动态。新的治疗药物和临床试验有助于製药业的成长。

轻度认知障碍市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 524% 左右的复合年增长率成长

根据适应症细分，由于阿兹海默症病例增加，预计阿兹海默症 (AD) 细分市场将在 2023 年显示最大的市场份额。

根据疾病类型细分，由于老年人中的盛行率较高，遗忘症部分将成为 2023 年的主要疾病类型。

根据年龄层细分，由于对阿兹海默症、血管性失智症等治疗的需求量很大，2023年老年病是领先的年龄层。

从地区来看，北美是 2023 年的主要收入来源，主要是由于阿兹海默症的高发生率。

轻度认知障碍市场-細項分析：

全球轻度认知障碍市场根据适应症、疾病类型、年龄层和地区进行细分。

根据适应症，市场分为五类：阿兹海默症、血管性失智症、路易氏体失智症、巴金森氏症痴呆症等。阿兹海默症痴呆细分市场占据主导地位。痴呆症的治疗需要轻度认知障碍，这有助于细分市场的成长。

根据疾病类型，市场分为两类：遗忘性 MCI 和非遗忘性 MCI。记忆删除 MCI 领域预计将占据最大的市场份额。遗忘症轻度认知障碍表示记忆力不足，病情并不严重，但在老年人中越来越多。

市场依年龄层分为三类：儿童、成人和老年人。老年医学领域在市场中占据主导地位，预计在预测期内将保持其高度主导地位。患有阿兹海默症和轻度认知障碍问题的老年人正在推动细分市场的需求。

轻度认知障碍市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。北美在轻度认知障碍市场中占据主导地位。美国老年人口数量庞大且不断增长，导致 MCI 盛行率较高。在研发方面进行了大量投资，并拥有支援早期诊断和治疗的先进医疗基础设施。在亚洲，日本的老年人比例很高，并且在认知障碍相关的研究和开发方面处于领先地位。该国拥有完善的管理 MCI 的医疗保健服务。

轻度认知障碍市场-竞争格局：

轻度认知障碍市场竞争中等。市场上的公司致力于开发旨在管理 MCI 和相关认知障碍的药物和疗法。 Biogen 和 Eli Lily 等公司正在开发阿兹海默症和其他可能与 MCI 重迭的神经退化性疾病的治疗方法。拥有强大研发管道的公司对于推进治疗和诊断至关重要。生物标记和药物开发的创新是关键的竞争因素。

最新进展：

2022 年 7 月，拉罗氏的 Elecsys 淀粉样蛋白血浆面板已获得 FDA 核准用于治疗阿兹海默症。

2022 年，梯瓦製药推出了用于轻度认知障碍护理的仿製药 Revlimid 胶囊。

目录

第一章：轻度认知障碍市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 轻度认知障碍市场片段（按适应症）
    • 按疾病类型分類的轻度认知障碍市场片段
    • 按年龄组别分類的轻度认知障碍市场片段
    • 按国家/地区分類的轻度认知障碍市场片段
    • 按地区分類的轻度认知障碍市场片段
  • 竞争洞察

第 3 章：轻度认知障碍主要市场趋势

  • 轻度认知障碍市场驱动因素
    • 市场驱动因素的影响分析
  • 轻度认知障碍市场限制
    • 市场限制影响分析
  • 轻度认知障碍市场机会
  • 轻度认知障碍市场未来趋势

第 4 章：轻度认知障碍产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：轻度认知障碍市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：轻度认知障碍市场格局

  • 2023 年轻认知障碍市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：轻度认知障碍市场 - 依适应症分类

  • 概述
    • 按指标分類的细分市场占有率分析
    • 阿兹海默症 痴呆
    • 血管性失智症
    • 路易氏体失智症
    • 帕金森氏症痴呆
    • 其他的

第 8 章：轻度认知障碍市场 - 按疾病类型

  • 概述
    • 按疾病类型分類的细分市场份额分析
    • 记忆删除MCI
    • 非记忆删除 MCI

第 9 章：轻度认知障碍市场 - 按年龄组

  • 概述
    • 按年龄组别分類的细分市场占有率分析
    • 孩子
    • 成人
    • 老年科

第 10 章：轻度认知障碍市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美轻度认知障碍主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按指标）
    • 北美市场规模和预测（按疾病类型）
    • 北美市场规模和预测（按年龄组）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲轻度认知障碍主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按指标）
    • 欧洲市场规模与预测（按疾病类型）
    • 欧洲市场规模和预测（按年龄层）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区轻度认知障碍主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依指标）
    • 亚太地区市场规模与预测（按疾病类型）
    • 亚太地区市场规模与预测（依年龄层）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲轻度认知障碍主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按指标）
    • 拉丁美洲市场规模与预测（按疾病类型）
    • 拉丁美洲市场规模与预测（按年龄层）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲轻度认知障碍主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（依指标）
    • 中东和非洲市场规模及预测（按疾病类型）
    • 中东和非洲市场规模及预测（按年龄层）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 轻度认知障碍产业

  • 竞争仪表板
  • 公司简介
    • Eli Lilly and Company
    • Biogen Inc.
    • Roche Holding AG
    • Axovant Gene Therapies Ltd.
    • GE Healthcare
    • Philips Healthcare
    • Neurotrack Technologies
    • Cogstate Ltd.
    • Lumosity Inc.
    • Alzheimer's Drug Discovery Foundation (ADDF)
    • AstraZeneca
    • Novartis International AG
    • Takeda Pharmaceutical Company Limited
    • Denali Therapeutics Inc.
    • HappyNeuron
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3526

REPORT HIGHLIGHT

Mild Cognitive Impairment Market size was valued at USD 1,980.21 Million in 2023, expanding at a CAGR of 5.24% from 2024 to 2032.

Mild Cognitive Impairment (MCI) is a kind of disease characterized by noticeable changes in cognitive function that are greater than expected for a person's age but not severe enough to interfere significantly with daily life. People with MCI might experience difficulties with memory, language, thinking, or judgment that are noticeable to themselves or others.

Mild Cognitive Impairment Market- Market Dynamics

The growing older population and advancement in diagnostic methods are expected to propel market demand

The prevalence of MCI and other cognitive disorders increases as the population rises. The growing number of older fuels demand diagnostic tools, treatments, and management strategies. There is a greater awareness and understanding of MCI among healthcare providers and the public. Advances in diagnostic methods and increased educational efforts contribute to higher detection rates and subsequent demand for interventions.

Further, increased healthcare spending on cognitive health and related areas drives demand for MCI-related products and services. Governments and private sectors are investing in better care solutions for cognitive disorders. The rise of digital health technologies, such as cognitive training apps, telemedicine, and wearable devices, enhances the management and monitoring of MCI. Technology improves patient engagement and provides new avenues for treatment and research. The development of drugs aimed at managing symptoms or modifying the progression of MCI influences market dynamics. New therapeutic agents and clinical trials contribute to growth in the pharmaceutical sector.

Mild Cognitive Impairment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 524% over the forecast period (2024-2032)

Based on Indication segmentation, the Alzheimer's disease (AD) segment was predicted to show maximum market share in the year 2023, owing to the increased prevalence of Alzheimer's disease.

Based on Disease Type segmentation, the amnestic segment was the leading Disease Type in 2023, due to high prevalence among older adults.

Based on Age Group segmentation, the geriatric segment was the leading Age Group in 2023, owing to the high need for treatment of Alzheimer's, vascular dementia, etc.

On the basis of region, North America was the leading revenue generator in 2023, mainly due to the high incidence of Alzheimer's disease.

Mild Cognitive Impairment Market- Segmentation Analysis:

The Global Mild Cognitive Impairment Market is segmented on the basis of Indication, Disease Type, Age Group, and Region.

The market is divided into five categories based on Indication: Alzheimer's Disease, Vascular Dementia, Lewy Body Dementia, Parkinson's Disease Dementia, and others. The Alzheimer's Disease Dementia segment dominates the market. Mild cognitive impairment is needed for dementia cure which is contributing to segment growth.

The market is divided into two categories based on Disease Type: amnestic MCI and non-amnestic MCI. The amnestic MCI segment is projected to hold the largest share of the market. Amnestic mild cognitive impairment indicates memory deficiency and is not so severe condition but is growing among old age people.

The market is divided into three categories based on Age Group: child, adult, and geriatric. The geriatric segment dominates the market and is expected to maintain its high dominance during the forecast period. Older age people suffering from Alzheimer's and having mild cognitive impairment issue are boosting segment demand.

Mild Cognitive Impairment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the Mild Cognitive Impairment market. The U.S. has a large and growing elderly population, contributing to a high prevalence of MCI. There is significant investment in research and development, along with advanced healthcare infrastructure that supports early diagnosis and treatment. In Asia, Japan has a high proportion of elderly individuals and is a leader in research and development related to cognitive impairments. The country has well-established healthcare services for managing MCI.

Mild Cognitive Impairment Market- Competitive Landscape:

The Mild Cognitive Impairment market is moderately competitive. The companies in the market are involved in developing drugs and therapies aimed at managing MCI and related cognitive disorders. Companies like Biogen and Eli Lily are developing treatments for Alzheimer's disease and other neurodegenerative conditions that can overlap with MCI. Companies with strong research and development pipelines are crucial in advancing treatments and diagnostics. Innovation in biomarkers and drug development are key competitive factors.

Recent Developments:

In July 2022, La Roche received FDA approval for the Elecsys Amyloid Plasma panel in the treatment of Alzheimer's disease.

In 2022, Teva Pharmaceuticals launched a generic Revlimid capsule for mild cognitive impairment care.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MILD COGNITIVE IMPAIRMENT MARKET KEY PLAYERS

  • Eli Lilly and Company
  • Biogen Inc.
  • Roche Holding AG
  • Axovant Gene Therapies Ltd.
  • GE Healthcare
  • Philips Healthcare
  • Neurotrack Technologies
  • Cogstate Ltd.
  • Lumosity Inc.
  • Alzheimer's Drug Discovery Foundation (ADDF)
  • AstraZeneca
  • Novartis International AG
  • Takeda Pharmaceutical Company Limited
  • Denali Therapeutics Inc.
  • HappyNeuron
  • Others

GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY INDICATION- MARKET ANALYSIS, 2019-2032

  • Alzheimer's Disease
  • Vascular Dementia
  • Lewy Body Dementia
  • Parkinson Disease Dementia
  • Others

GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Amnestic MCI
  • Non-amnestic MCI

GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY AGE GROUP- MARKET ANALYSIS, 2019-2032

  • Child
  • Adult
  • Geriatric

GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Mild Cognitive Impairment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Mild Cognitive Impairment Market Snippet by Indication
    • 2.1.2. Mild Cognitive Impairment Market Snippet by Disease Type
    • 2.1.3. Mild Cognitive Impairment Market Snippet by Age Group
    • 2.1.4. Mild Cognitive Impairment Market Snippet by Country
    • 2.1.5. Mild Cognitive Impairment Market Snippet by Region
  • 2.2. Competitive Insights

3. Mild Cognitive Impairment Key Market Trends

  • 3.1. Mild Cognitive Impairment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Mild Cognitive Impairment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Mild Cognitive Impairment Market Opportunities
  • 3.4. Mild Cognitive Impairment Market Future Trends

4. Mild Cognitive Impairment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Mild Cognitive Impairment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Mild Cognitive Impairment Market Landscape

  • 6.1. Mild Cognitive Impairment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Mild Cognitive Impairment Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
    • 7.1.2. Alzheimer's Disease Dementia
    • 7.1.3. Vascular Dementia
    • 7.1.4. Lewy Body Dementia
    • 7.1.5. Parkinson Disease Dementia
    • 7.1.6. Others

8. Mild Cognitive Impairment Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 8.1.2. Amnestic MCI
    • 8.1.3. Non-amnestic MCI

9. Mild Cognitive Impairment Market - By Age Group

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Age Group, 2024 & 2032 (%)
    • 9.1.2. Child
    • 9.1.3. Adult
    • 9.1.4. Geriatric

10. Mild Cognitive Impairment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Mild Cognitive Impairment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Mild Cognitive Impairment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Mild Cognitive Impairment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Mild Cognitive Impairment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Mild Cognitive Impairment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Mild Cognitive Impairment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Eli Lilly and Company
    • 11.2.2. Biogen Inc.
    • 11.2.3. Roche Holding AG
    • 11.2.4. Axovant Gene Therapies Ltd.
    • 11.2.5. GE Healthcare
    • 11.2.6. Philips Healthcare
    • 11.2.7. Neurotrack Technologies
    • 11.2.8. Cogstate Ltd.
    • 11.2.9. Lumosity Inc.
    • 11.2.10. Alzheimer's Drug Discovery Foundation (ADDF)
    • 11.2.11. AstraZeneca
    • 11.2.12. Novartis International AG
    • 11.2.13. Takeda Pharmaceutical Company Limited
    • 11.2.14. Denali Therapeutics Inc.
    • 11.2.15. HappyNeuron
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Mild Cognitive Impairment Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Mild Cognitive Impairment Market, by Indication 2019-2032 (USD Million)
  • TABLE Mild Cognitive Impairment Market: Disease Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Mild Cognitive Impairment Market, by Disease Type 2019-2032 (USD Million)
  • TABLE Mild Cognitive Impairment Market: Age Group Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Age Group
  • TABLE Global Mild Cognitive Impairment Market, by Age Group 2019-2032 (USD Million)
  • TABLE Mild Cognitive Impairment Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Mild Cognitive Impairment Market, by Region 2019-2032 (USD Million)
  • TABLE North America Mild Cognitive Impairment Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Mild Cognitive Impairment Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Mild Cognitive Impairment Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE North America Mild Cognitive Impairment Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Europe Mild Cognitive Impairment Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Mild Cognitive Impairment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Mild Cognitive Impairment Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Europe Mild Cognitive Impairment Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mild Cognitive Impairment Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mild Cognitive Impairment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mild Cognitive Impairment Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mild Cognitive Impairment Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Latin America Mild Cognitive Impairment Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Mild Cognitive Impairment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Mild Cognitive Impairment Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Latin America Mild Cognitive Impairment Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mild Cognitive Impairment Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mild Cognitive Impairment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mild Cognitive Impairment Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mild Cognitive Impairment Market, by Age Group, 2019-2032 (USD Million)

List of Figures

  • FIGURE Mild Cognitive Impairment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Indication segment market share analysis, 2023 & 2032
  • FIGURE Indication segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Disease Type segment market share analysis, 2023 & 2032
  • FIGURE Disease Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Age Group segment market share analysis, 2023 & 2032
  • FIGURE Age Group segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Mild Cognitive Impairment Market share and leading players, 2023
  • FIGURE Europe Mild Cognitive Impairment Market share and leading players, 2023
  • FIGURE Asia Pacific Mild Cognitive Impairment Market share and leading players, 2023
  • FIGURE Latin America Mild Cognitive Impairment Market share and leading players, 2023
  • FIGURE Middle East and Africa Mild Cognitive Impairment Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Mild Cognitive Impairment Market share analysis by country, 2023
  • FIGURE Germany Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Mild Cognitive Impairment Market share analysis by country, 2023
  • FIGURE India Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Mild Cognitive Impairment Market share analysis by country, 2023
  • FIGURE Brazil Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Mild Cognitive Impairment Market share analysis by country, 2023
  • FIGURE Saudi Arabia Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)